Why Amazon is splitting its shares
Slicing a cake into more pieces doesn’t give you more cake. So why is Amazon dividing its shares by 20?


Amazon has just announced a stock split for the first time since the dotcom bubble years. It’s the fourth such split in the company’s near-30-year history. Assuming the move is approved at the annual general meeting in May, then from 6 June, Amazon’s investors will get 19 extra shares for each one they already hold (what’s known as a 20-for-one split). Alphabet – Google’s parent company – did the same thing last month, for only the second time since it went public in 2004.
To be very clear, share splits make no difference to the value of the company. It’s as if I gave you a cake, then said I was going to cut it into 20 slices. You’d still have exactly the same amount of cake (for the pedants out there, we’ll assume no loss to crumbling or sticking to the knife). Yet the share price bounced significantly on the news. So to ask the obvious question: what’s the point of doing this, and why the excitement?
What’s the point?
The rationale often given for stock splits is to reduce the price of an individual share, thus making them more accessible – and indeed, that’s how Amazon spun it. Yet as we note below, this isn’t all that convincing, particularly in these days, when fractional share ownership is possible.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Bloomberg’s Jonathan Levin and Eric Savitz in Barron’s suggest a more convincing reason why Amazon and Alphabet might want to consider stock splits. It’s all about getting more exposure to index-tracking funds. How? Alongside the S&P 500, the Dow Jones Industrial Average is the best-known stock index in the US. It comprises 30 big-name US companies. However, it’s built in a way that may have made sense when it was launched in 1896, but no longer does. The S&P 500 – like most headline market indices – is based on market capitalisation (the share price multiplied by the number of shares in issue). In short, the bigger the market cap, the greater its weighting in the index.
By contrast, the Dow is weighted simply by share price. For example, UnitedHealth Group is the top-weighted Dow stock with a share price of around $500. Intel is the lowest, on $45. Yet United’s market cap of $460bn is less than three times that of Intel on $181bn. As a result of this odd methodology, the committee makes sure that the highest-priced stock in the index remains roughly ten times the price of the lowest. That means Amazon or Alphabet on share prices of around $2,500-$3,000 are simply too pricey for the Dow (whereas Apple, a fellow tech giant, is in the Dow with a share price of around $150). A 20-for-one split will put both in the running for the Dow – and all that lovely passive money flow.
John is the executive editor of MoneyWeek and writes our daily investment email, Money Morning. John graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news. John joined MoneyWeek in 2005.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
Nationwide: UK house prices creep up by 0.2% - are we heading for a rebound?
Nationwide’s latest house price index shows property prices inched up by 0.2% as demand warms up - will this trend go into 2024?
By Kalpana Fitzpatrick Published
-
December 2023 NS&I Premium Bond winners revealed - have you won the jackpot?
Two Premium Bond holders are now millionaires as NS&I reveals December winners. Find out if you’re one of them
By Vaishali Varu Published
-
M&S shares shift from frumpy to fabulous as pre-tax profits are up by 56%
M&S is performing strongly and has announced it will pay a dividend for the first time since the pandemic.
By Dr Matthew Partridge Published
-
The rise and fall of Sam Bankman-Fried – the “boy wonder of crypto”
Why the fate of Sam Bankman-Fried reminds us to be wary of digital tokens and unregulated financial intermediaries.
By Jane Lewis Published
-
Three defence stocks set to flourish in an era of instability
A professional investor tells MoneyWeek where he’d put his money. Tom Bailey highlights three defence stocks that look promising.
By Tom Bailey Published
-
EasyJet shares rise after record results
The EasyJet group has shrugged off the cost-of-living crisis, restarted dividends and shares look good value.
By Dr Matthew Partridge Last updated
-
The fallout from the war on landlords
Investors fleeing the market and the rise in rents are affecting us all.
By Charlie Ellingworth Published
-
Eight small-cap trusts to bet on
Funds investing in market minnows are out of favour, but the cycle will turn. Here are the best bets.
By Max King Published
-
Trust in US TIPS to beat inflation
In an inflationary market TIPS, the US Treasury Inflation-Protected Securities are most compelling says Cris Sholto Heaton.
By Cris Sholto Heaton Published
-
What is Vix – the fear index?
What is Vix? We explain how the fear index could guide your investment decisions.
By Dr Matthew Partridge Published